Showing results (31-40 of 58) with videos related to
Sort By:
Pageof 6
Medical and Pediatric Oncology|January 1, 1978
A preliminary study of cyclophosphamide (NSC-26271), adriamycin (NSC-123127), imidazole carboxamide (NSC-45388), and actinomycin D (NSC-3053) with or without MER-BCG in patients with advanced sarcomasE T Creagan, J H Edmonson, R G Hahn, et al.JAMA|November 9, 1979
Complete responders to chemotherapy in metastatic breast cancer. Characterization and analysisD A Decker, D L Ahmann, H F Bisel, et al.The New England Journal of Medicine|August 18, 1977
An evaluation of early or delayed adjuvant chemotherapy in premenopausal patients with advanced breast cancer undergoing oophorectomyD L Ahmann, M J O'Connell, R G Hahn, et al.Cancer|May 1, 1978
A quantitative approach to determining disease response during therapy using multiple biologic markers: application to carcinoma of the breastK B Woo, T P Waalkes, D L Ahmann, et al.Cancer|January 15, 1989
Complete responses and long-term survivals after systemic chemotherapy for patients with advanced malignant melanomaD L Ahmann, E T Creagan, R G Hahn, et al.Cancer Research|August 1, 1982
Progress report on two clinical trials in women with advanced breast cancer. Trial I: tamoxifen versus tamoxifen plus aminoglutethimide. Trial II: aminoglutethimide in patients with prior tamoxifen exposureJ N Ingle, S J Green, D L Ahmann, et al.Cancer Clinical Trials|January 1, 1979
Treatment of advanced breast cancer with cyclophosphamide, 5-fluorouracil, and prednisone with and without methanol-extracted residue of BCGJ C Britell, D L Ahmann, H F Bisel, et al.Clinical Pharmacology and Therapeutics|June 1, 1976
Clinical comparison of adriamycin and a combination of methyl-CCNU and imidazole carboxamide in disseminated malignant melanomaD L Ahmann, H F Bisel, J H Edmonson, et al.American Journal of Clinical Oncology|April 1, 1982
Randomized clinical trial of megestrol acetate versus tamoxifen in paramenopausal or castrated women with advanced breast cancerJ N Ingle, D L Ahmann, S J Green, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1984
Phase II study of low-dose recombinant leukocyte A interferon in disseminated malignant melanomaE T Creagan, D L Ahmann, S J Green, et al.Pageof 6